Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD

References

• Aleksandrova, L. R., and A. G. Phillips. 2021. Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics. Trends in Pharmacological Sciences 42 (11):929–42. doi:10.1016/j.tips.2021.08.003.
   PubMed Web of Science ®Google Scholar
• Anthony, J., A. Winstock, J. Ferris, and D. Nutt. 2020. Improved colour blindness symptoms associated with recreational psychedelic use: Results from the global drug survey 2017. Drug Science, Policy and Law 6:205032452094234. doi:10.1177/2050324520942345.
   Google Scholar
• Barnett, B. S., N. W. Sweat, and P. S. Hendricks. 2023. Case report: Prolonged amelioration of mild red-green color vision deficiency following psilocybin mushroom use. Drug Science, Policy and Law 9:205032452311725. doi:10.1177/20503245231172536.
   Google Scholar
• Barrett, F. S., M. W. Johnson, and R. R. Griffiths. 2015. Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin. Journal of Psychopharmacology 29 (11):1182–90. doi:10.1177/0269881115609019.
   PubMed Web of Science ®Google Scholar
• Bogenschutz, M. P., A. A. Forcehimes, J. A. Pommy, C. E. Wilcox, P. Barbosa, and R. J. Strassman. 2015. Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology 29 (3):289–99. doi:10.1177/0269881114565144.
   PubMed Web of Science ®Google Scholar
• Brann, D. H., T. Tsukahara, C. Weinreb, M. Lipovsek, K. Van den Berge, B. Gong, R. Chance, I. C. Macaulay, H.-J. Chou, R. B. Fletcher, et al. 2020. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Science Advances 6 (31). doi: 10.1126/sciadv.abc5801.
   PubMed Web of Science ®Google Scholar
• Brill, J., Z. Shao, A. C. Puche, M. Wachowiak, and M. T. Shipley. 2016. Serotonin increases synaptic activity in olfactory bulb glomeruli. Journal of Neurophysiology 115 (3):1208–19. doi:10.1152/jn.00847.2015.
   PubMed Web of Science ®Google Scholar
• Calder, A. E., and G. Hasler. 2023. Towards an understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacology 48 (1):104–12. doi:10.1038/s41386-022-01389-z.
   PubMed Web of Science ®Google Scholar
• Chapin, S. 2021, July 28.COVID-19 Took My Sense of Smell, Then LSD Brought It Back. Substack. https://sashachapin.substack.com/p/covid-19-took-my-sense-of-smell-then?s=r
   Google Scholar
• Colle, R., K. el Asmar, C. Verstuyft, P. M. Lledo, F. Lazarini, K. Chappell, E. Deflesselle, A. el Kader Ait Tayeb, B. Falissard, E. Duron, et al. 2020. The olfactory deficits of depressed patients are restored after remission with venlafaxine treatment. Psychological Medicine 52 (11):2062–70. doi:10.1017/S0033291720003918.
   Web of Science ®Google Scholar
• Croy, I., S. Nordin, and T. Hummel. 2014. Olfactory disorders and quality of life–an updated review. Chemical Senses 39 (3):185–94. doi:10.1093/chemse/bjt072.
   PubMed Web of Science ®Google Scholar
• Damm, M., L. K. Pikart, H. Reimann, S. Burkert, Ö. Göktas, B. Haxel, S. Frey, I. Charalampakis, A. Beule, B. Renner, et al. 2014. Olfactory training is helpful in postinfectious olfactory loss: A randomized, controlled, multicenter study. The Laryngoscope 124 (4):826–31. doi:10.1002/lary.24340.
   PubMed Web of Science ®Google Scholar
• de Vos, C. M. H., N. L. Mason, and K. P. C. Kuypers. 2021. Psychedelics and neuroplasticity: A systematic review unraveling the biological underpinnings of psychedelics. Frontiers in Psychiatry 12:12. doi:10.3389/fpsyt.2021.724606.
   Web of Science ®Google Scholar
• dos Santos, R. G., J. C. Bouso, M. Á. Alcázar-Córcoles, and J. E. C. Hallak. 2018. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: A systematic review of systematic reviews. Expert Review of Clinical Pharmacology 11 (9):889–902. doi:10.1080/17512433.2018.1511424.
   PubMed Web of Science ®Google Scholar
• Dos Santos, R. G., and J. E. C. Hallak. 2020. Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms. Neuroscience and Biobehavioral Reviews 108:423–34. doi:10.1016/j.neubiorev.2019.12.001.
   PubMed Web of Science ®Google Scholar
• Doty, R. L., P. Shaman, C. P. Kimmelman, and M. S. Dann. 1984. University of Pennsylvania smell identification test: A rapid quantitative olfactory function test for the clinic. The Laryngoscope 94 (2):176–78. doi:10.1288/00005537-198402000-00004.
   PubMed Web of Science ®Google Scholar
• Dugué, G. P., and Z. F. Mainen. 2009. How serotonin gates olfactory information flow. Nature Neuroscience 12 (6):673–75. doi:10.1038/nn0609-673.
   PubMed Web of Science ®Google Scholar
• Flanagan, T. W., and C. D. Nichols. 2018. Psychedelics as anti-inflammatory agents. International Review of Psychiatry 30 (4):363–75. doi:10.1080/09540261.2018.1481827.
   PubMed Web of Science ®Google Scholar
• Frere, J. J., R. A. Serafini, K. D. Pryce, M. Zazhytska, K. Oishi, I. Golynker, M. Panis, J. Zimering, S. Horiuchi, D. A. Hoagland, et al. 2022. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Science Translational Medicine 14 (664). doi: 10.1126/scitranslmed.abq3059.
   PubMed Web of Science ®Google Scholar
• Garcia-Romeu, A., R. R. Griffiths, and M. W. Johnson. 2014. Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Current Drug Abuse Reviews 7 (3):157–64. doi:10.2174/1874473708666150107121331.
   PubMedGoogle Scholar
• Gaudry, Q. 2018. Serotonergic modulation of olfaction in rodents and insects. The Yale Journal of Biology and Medicine 91 (1):23–32.
   PubMed Web of Science ®Google Scholar
• Gukasyan, N., A. K. Davis, F. S. Barrett, M. P. Cosimano, N. D. Sepeda, M. W. Johnson, and R. R. Griffiths. 2022. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Journal of Psychopharmacology 36 (2):151–58. doi:10.1177/02698811211073759.
   PubMed Web of Science ®Google Scholar
• Hartig, P. R., U. Scheffel, J. J. Frost, and H. N. Wagner. 1985. In vivo binding of 125I-LSD to serotonin 5-HT2 receptors in mouse brain. Life Sciences 37 (7):657–64. doi:10.1016/0024-3205(85)90433-3.
   PubMed Web of Science ®Google Scholar
• Harvey, J. D., and T. Heinbockel. 2018. Neuromodulation of synaptic transmission in the main olfactory bulb. International Journal of Environmental Research and Public Health 15 (10):2194. doi:10.3390/ijerph15102194.
   PubMed Web of Science ®Google Scholar
• Holze, F., P. Vizeli, L. Ley, F. Müller, P. Dolder, M. Stocker, U. Duthaler, N. Varghese, A. Eckert, S. Borgwardt, et al. 2021. Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology 46 (3):537–44. doi:10.1038/s41386-020-00883-6.
   PubMed Web of Science ®Google Scholar
• Inserra, A., D. De Gregorio, and G. Gobbi. 2021a. Psychedelics in psychiatry: Neuroplastic, immunomodulatory, and neurotransmitter mechanisms. Pharmacological Reviews 73 (1):202–77. doi:10.1124/pharmrev.120.000056.
   PubMed Web of Science ®Google Scholar
• Johnson, M. W., P. S. Hendricks, F. S. Barrett, and R. R. Griffiths. 2019. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology & Therapeutics 197:83–102. doi:10.1016/j.pharmthera.2018.11.010.
   PubMed Web of Science ®Google Scholar
• Kalogjera, L., and D. Dzepina. 2012. Management of smell dysfunction. Current Allergy and Asthma Reports 12 (2):154–62. doi:10.1007/s11882-012-0248-5.
   Web of Science ®Google Scholar
• Kandalaft, I., N. Khazan, and F. G. Sulman. 1967. EEG activity of the olfactory bulb of the unrestrained rabbit under LSD-25 and chlorpromazine. Electroencephalography and Clinical Neurophysiology 22 (6):589–90.
   PubMedGoogle Scholar
• Käufer, C., C. S. Schreiber, A.-S. Hartke, I. Denden, S. Stanelle-Bertram, S. Beck, N. M. Kouassi, G. Beythien, K. Becker, T. Schreiner, et al. 2022. Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model. E Bio Medicine 79:103999. doi:10.1016/j.ebiom.2022.103999.
   Google Scholar
• Kishimoto-Urata, M., S. Urata, R. Kagoya, F. Imamura, S. Nagayama, R. A. Reyna, J. Maruyama, T. Yamasoba, K. Kondo, S. Hasegawa-Ishii, et al. 2022. Prolonged and extended impacts of SARS-CoV-2 on the olfactory neurocircuit. Scientific Reports 12 (1):5728. doi:10.1038/s41598-022-09731-7.
   PubMed Web of Science ®Google Scholar
• Kohli, P., Z. M. Soler, S. A. Nguyen, J. S. Muus, and R. J. Schlosser. 2016. The association between olfaction and depression: A systematic review. Chemical Senses 41 (6):479–86. doi:10.1093/chemse/bjw061.
   PubMed Web of Science ®Google Scholar
• LaFever, B. J., and F. Imamura. 2022. Effects of nasal inflammation on the olfactory bulb. Journal of Neuroinflammation 19 (1):294. doi:10.1186/s12974-022-02657-x.
   PubMed Web of Science ®Google Scholar
• Lechien, J. R., C. M. Chiesa‐Estomba, E. Beckers, V. Mustin, M. Ducarme, F. Journe, A. Marchant, L. Jouffe, M. R. Barillari, G. Cammaroto, et al. 2021. Prevalence and 6‐month recovery of olfactory dysfunction: A multicentre study of 1363 COVID‐19 patients. Journal of Internal Medicine 290 (2):451–61. doi:10.1111/joim.13209.
   PubMed Web of Science ®Google Scholar
• Lechien, J. R., C. M. Chiesa‐Estomba, S. Place, Y. Van Laethem, P. Cabaraux, Q. Mat, K. Huet, J. Plzak, M. Horoi, S. Hans, et al. 2020. Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019. Journal of Internal Medicine 288 (3):335–44. doi:10.1111/joim.13089.
   PubMed Web of Science ®Google Scholar
• Lizbinski, K. M., and A. M. Dacks. 2018. Intrinsic and extrinsic neuromodulation of olfactory processing. In Frontiers in cellular neuroscience, Vol. 11. Frontiers Media S.A. doi:10.3389/fncel.2017.00424.
   Google Scholar
• López-Giménez, J. F., and J. González-Maeso. 2018. Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways. Current Topics in Behavioral Neurosciences 36:45–73. doi:10.1007/7854_2017_478.
   PubMedGoogle Scholar
• Ly, C., A. C. Greb, L. P. Cameron, J. M. Wong, E. V. Barragan, P. C. Wilson, K. F. Burbach, S. Soltanzadeh Zarandi, A. Sood, M. R. Paddy, et al. 2018. Psychedelics promote structural and functional neural plasticity. Cell Reports 23 (11):3170–82. doi:10.1016/j.celrep.2018.05.022.
   PubMed Web of Science ®Google Scholar
• Mckenna, D. J., A. J. Nazarali, A. J. Hoffman, D. E. Nichols, C. A. Mathis, and J. M. Saavedra. 1989. Common receptors for hallucinogens in rat brain: A comparative autoradiographic study using [125I]LSD and [125I]DOI, a new psychotomimetic radioligand. Brain Research 476 (1):45–56. doi:10.1016/0006-8993(89)91535-7.
   PubMed Web of Science ®Google Scholar
• McLean, M. 2020, February 20. Man Magically Regains His Sense of Smell Using Psilocybin Mushrooms. Double Blind. https://thankyouplantmedicine.com/man-regains-his-lost-sense-of-smell-using-psilocybin-mushrooms/
   Google Scholar
• Meng, X., and Y. Pan. 2021. COVID-19 and anosmia: The story so far. Ear, Nose & Throat Journal 014556132110489. doi:10.1177/01455613211048998.
   Web of Science ®Google Scholar
• Miwa, T., K. Ikeda, T. Ishibashi, M. Kobayashi, K. Kondo, Y. Matsuwaki, T. Ogawa, H. Shiga, M. Suzuki, K. Tsuzuki, et al. 2019. Clinical practice guidelines for the management of olfactory dysfunction — secondary publication. Auris Nasus Larynx 46 (5):653–62. doi:10.1016/j.anl.2019.04.002.
   PubMed Web of Science ®Google Scholar
• Moliner, R., M. Girych, C. A. Brunello, V. Kovaleva, C. Biojone, G. Enkavi, L. Antenucci, E. F. Kot, S. A. Goncharuk, K. Kaurinkoski, et al. 2023. Psychedelics promote plasticity by directly binding to BDNF receptor TrkB. Nature Neuroscience 26 (6):1032–41. doi:10.1038/s41593-023-01316-5.
   PubMed Web of Science ®Google Scholar
• Moncrieff, J., R. E. Cooper, T. Stockmann, S. Amendola, M. P. Hengartner, and M. A. Horowitz. 2022. The serotonin theory of depression: A systematic umbrella review of the evidence. Molecular Psychiatry. doi:10.1038/s41380-022-01661-0.
   PubMed Web of Science ®Google Scholar
• Morris, H. 2021. An anecdotal report of 2C-B temporarily reversing COVID-associated anosmia and ageusia. In Twitter. https://twitter.com/hamiltonmorris/status/1355622848400936963
   Google Scholar
• Mott, A. E., and D. A. Leopold. 1991. Disorders in taste and smell. Medical Clinics of North America 75 (6):1321–53. doi:10.1016/S0025-7125(16)30391-1.
   PubMed Web of Science ®Google Scholar
• Mutiawati, E., M. Fahriani, S. S. Mamada, J. K. Fajar, A. Frediansyah, H. A. Maliga, M. Ilmawan, T. B. Emran, Y. Ophinni, I. Ichsan, et al. 2021. Anosmia and dysgeusia in SARS-CoV-2 infection: Incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis. F1000research 10:40. doi:10.12688/f1000research.28393.1.
   PubMedGoogle Scholar
• Nag, A. K., A. K. Saltagi, M. Z. Saltagi, A. W. Wu, T. S. Higgins, A. Knisely, J. Y. Ting, and E. A. Illing. 2023. Management of post-infectious anosmia and hyposmia: A systematic review. Annals of Otology, Rhinology & Laryngology 132 (7):806–17. doi:10.1177/00034894221118186.
   PubMed Web of Science ®Google Scholar
• Nakada, M. T., C. M. Wieczorek, and T. C. Rainbow. 1984. Localization and characterization by quantitative autoradiography of [125I]LSD binding sites in rat brain. Neuroscience Letters 49 (1–2):13–18. doi:10.1016/0304-3940(84)90128-9.
   PubMed Web of Science ®Google Scholar
• Nau, F., B. Yu, D. Martin, C. D. Nichols, and M. Bader. 2013. Serotonin 5-HT2A receptor activation blocks TNF-α mediated inflammation in vivo. PLoS ONE 8 (10):e75426. doi:10.1371/journal.pone.0075426.
   PubMed Web of Science ®Google Scholar
• Nichols, C. D., and E. Sanders-Bush. 2002. A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 26 (5):634–42. doi:10.1016/S0893-133X(01)00405-5.
   PubMed Web of Science ®Google Scholar
• Patel, Z. M., S. K. Wise, and J. M. DelGaudio. 2017. Randomized controlled trial demonstrating cost-effective method of olfactory training in clinical practice: Essential oils at uncontrolled concentration. Laryngoscope Investigative Otolaryngology 2 (2):53–56. doi:10.1002/lio2.62.
   PubMedGoogle Scholar
• Preller, K. H., M. Herdener, T. Pokorny, A. Planzer, R. Kraehenmann, P. Stämpfli, M. E. Liechti, E. Seifritz, and F. X. Vollenweider. 2017. The fabric of meaning and subjective effects in LSD-Induced states depend on serotonin 2A receptor activation. Current Biology 27 (3):451–57. doi:10.1016/j.cub.2016.12.030.
   PubMed Web of Science ®Google Scholar
• Roseman, L., D. J. Nutt, and R. L. Carhart-Harris. 2018. Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Frontiers in Pharmacology 8:8. doi:10.3389/fphar.2017.00974.
   Web of Science ®Google Scholar
• Rousseau, C., and J. Malaty. 2021. Dysosmia and drug tolerance with use of venlafaxine. BMJ Case Reports 14 (4):e240547. doi:10.1136/bcr-2020-240547.
   PubMedGoogle Scholar
• Schlag, A. K., J. Aday, I. Salam, J. C. Neill, and D. J. Nutt. 2022. Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Journal of Psychopharmacology 36 (3):258–72. doi:10.1177/02698811211069100.
   PubMed Web of Science ®Google Scholar
• Sen, A. 2021. Does serotonin deficiency lead to anosmia, ageusia, dysfunctional chemesthesis and increased severity of illness in COVID-19? Medical Hypotheses 153:153. doi:10.1016/j.mehy.2021.110627.
   Web of Science ®Google Scholar
• Singh, A. P., R. N. Das, G. Rao, A. Aggarwal, S. Diegelmann, J. F. Evers, H. Karandikar, M. Landgraf, V. Rodrigues, K. VijayRaghavan, et al. 2013. Sensory neuron-derived eph regulates glomerular arbors and modulatory function of a central serotonergic neuron. PLoS Genetics 9 (4):e1003452. doi:10.1371/journal.pgen.1003452.
   PubMed Web of Science ®Google Scholar
• Siopi, E., M. Denizet, M. M. Gabellec, F. de Chaumont, J. C. Olivo-Marin, J. P. Guilloux, P. M. Lledo, and F. Lazarini. 2016. Anxiety- and depression-like states lead to pronounced olfactory deficits and impaired adult neurogenesis in mice. Journal of Neuroscience 36 (2):518–31. doi:10.1523/JNEUROSCI.2817-15.2016.
   PubMed Web of Science ®Google Scholar
• Torabi, A., E. Mohammadbagheri, N. Akbari Dilmaghani, A.-H. Bayat, M. Fathi, K. Vakili, R. Alizadeh, O. Rezaeimirghaed, M. Hajiesmaeili, M. Ramezani, et al. 2020. Proinflammatory cytokines in the olfactory mucosa result in COVID-19 induced anosmia. ACS Chemical Neuroscience 11 (13):1909–13. doi:10.1021/acschemneuro.0c00249.
   PubMed Web of Science ®Google Scholar
• Vargas, M. V., L. E. Dunlap, C. Dong, S. J. Carter, R. J. Tombari, S. A. Jami, L. P. Cameron, S. D. Patel, J. J. Hennessey, H. N. Saeger, et al. 2023. Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. Science 379 (6633):700–06. doi:10.1126/science.adf0435.
   PubMed Web of Science ®Google Scholar
• Watts, S. W., S. L. Gackenheimer, D. R. Gehlert, and M. L. Cohen. 1994. Autoradiographic comparison of [125I]LSD-labeled 5-HT2A receptor distribution in rat and guinea pig brain. Neurochemistry International 24 (6):565–74. doi:10.1016/0197-0186(94)90009-4.
   PubMed Web of Science ®Google Scholar
• Yoshida, K., T. Fukuchi, and H. Sugawara. 2017. Dysosmia and dysgeusia associated with duloxetine. BMJ Case Reports 2017. doi:10.1136/bcr-2017-222470.
   Google Scholar
• Yu, B., J. Becnel, M. Zerfaoui, R. Rohatgi, A. H. Boulares, and C. D. Nichols. 2008. Serotonin 5-hydroxytryptamine 2a receptor activation suppresses tumor necrosis factor-α-induced inflammation with extraordinary potency. Journal of Pharmacology and Experimental Therapeutics 327 (2):316–23. doi:10.1124/jpet.108.143461.
   PubMed Web of Science ®Google Scholar
• Zazhytska, M., A. Kodra, D. A. Hoagland, J. Frere, J. F. Fullard, H. Shayya, N. G. McArthur, R. Moeller, S. Uhl, A. D. Omer, et al. 2022. Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia. Cell 185 (6):1052–64.e12. doi:10.1016/j.cell.2022.01.024.
   PubMed Web of Science ®Google Scholar